Early research (Phase 1)Study completedNCT05065710What this trial is testingZL-1211 in Patients With Advanced Solid TumorWho this might be right forAdvanced Solid Tumor Zai Biopharmaceutical (Suzhou) Co., Ltd. 34
Early research (Phase 1)Ended earlyNCT03871348What this trial is testingA First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsWho this might be right forMetastatic Neoplasm Sanofi 77
Testing effectiveness (Phase 2)Looking for participantsNCT05636215What this trial is testingA First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid TumorsWho this might be right forLocally Advanced Unresectable or Metastatic Solid Tumors Innovent Biologics (Suzhou) Co. Ltd. 368
Early research (Phase 1)Study completedNCT00499135What this trial is testingSunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid TumorsWho this might be right forAdult Solid NeoplasmClear Cell Renal Cell CarcinomaRecurrent Renal Cell Carcinoma+2 more National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT00313508What this trial is testingDendritic Cell Vaccination During Lymphoid ReconstructionWho this might be right forIntraocular MelanomaMelanoma (Skin) H. Lee Moffitt Cancer Center and Research Institute 18
Large-scale testing (Phase 3)Study completedNCT00931008What this trial is testingStudy to Evaluate SID 530 Compared to TaxotereWho this might be right forNon-Small Cell Lung Cancer SK Chemicals Co., Ltd. 42
Testing effectiveness (Phase 2)Study completedNCT02344017What this trial is testingSafety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forProstate Cancer Orion Corporation, Orion Pharma 23
Not applicableWithdrawnNCT01434550What this trial is testingPhase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic CancerWho this might be right forPancreatic Tumor H. Lee Moffitt Cancer Center and Research Institute
Not applicableStudy completedNCT01631318What this trial is testingPilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver MetastasesWho this might be right forLiver MetastasesColon Cancer Stanford University 34
Testing effectiveness (Phase 2)Looking for participantsNCT04724018What this trial is testingSacituzumab Govitecan Plus EV in Metastatic UCWho this might be right forUrothelial CancerMetastatic Urothelial CarcinomaMetastatic Urothelial Carcinoma of the Renal Pelvis and Ureter+1 more Dana-Farber Cancer Institute 106
Testing effectiveness (Phase 2)Ended earlyNCT00845910What this trial is testingCirculating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 22
Not applicableStudy completedNCT01083849What this trial is testingLong-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical PracticeWho this might be right forKidney InsufficiencySecondary Hyperparathyroidism AbbVie (prior sponsor, Abbott) 761
Not applicableLooking for participantsNCT07052578What this trial is testingAggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDerationWho this might be right forProstate Cancer AstraZeneca 400
Testing effectiveness (Phase 2)UnknownNCT01318785What this trial is testingTherapeutical Assessment of Compression Armsleeves for Lymphatic IndicationsWho this might be right forLymphedema University Medicine Greifswald 40
Testing effectiveness (Phase 2)Study completedNCT02439385What this trial is testingAvastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable MetastasisWho this might be right forColorectal Cancer Gachon University Gil Medical Center 44
Testing effectiveness (Phase 2)Looking for participantsNCT06860815What this trial is testingCemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Carcinoma in the Liver City of Hope Medical Center 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT02671435What this trial is testingDurvalumab (MEDI4736) and Monalizumab in Solid TumorsWho this might be right forAdvanced Solid Tumors MedImmune LLC 383
Testing effectiveness (Phase 2)Study completedNCT01271725What this trial is testingLUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment FailuresWho this might be right forBreast Neoplasms Boehringer Ingelheim 74
Testing effectiveness (Phase 2)Ended earlyNCT00538291What this trial is testingCetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan TreatmentWho this might be right forColorectal Cancer City of Hope Medical Center 13
Large-scale testing (Phase 3)UnknownNCT00532818What this trial is testingHydralazine Valproate for Cervical CancerWho this might be right forMetastatic Cervical Cancer National Institute of Cancerología 143